Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
History
Epicardial Mapping
Transition From an ICU
Integrating Collaborat
Gangliosidosis, GM1
Pioglitazone in early
See All (24) pages
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol. 2015 Aug; 14(8):795-803.
View in:
PubMed
subject areas
Aged
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Indans
Male
Medical Futility
Middle Aged
Neuroprotective Agents
Parkinson Disease
Selegiline
Thiazolidinediones
Treatment Outcome
authors with profiles
Rohit Dhall
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.